New insights into a microvascular invasion prediction model in hepatocellular carcinoma: A retrospective study from the SEER database and China

Background and Aims The prognosis of liver cancer is strongly influenced by microvascular infiltration (MVI). Accurate preoperative MVI prediction can aid clinicians in the selection of suitable treatment options. In this study, we constructed a novel, reliable, and adaptable nomogram for predicting MVI. Methods Using the Surveillance, Epidemiology, and End Results (SEER) database, we extracted the clinical data of 1,063 patients diagnosed with hepatocellular carcinoma (HCC) and divided it into either a training (n = 739) or an internal validation cohort (n = 326). Based on multivariate analysis, the training cohort data were analyzed and a nomogram was generated for MVI prediction. This was further verified using an internal validation cohort and an external validation cohort involving 293 Chinese patients. Furthermore, to evaluate the efficacy, accuracy, and clinical use of the nomogram, we used concordance index (C-index), calibration curve, and decision curve analysis (DCA) techniques. Results In accordance with the multivariate analysis, tumor size, tumor number, alpha-fetoprotein (AFP), and histological grade were independently associated with MVI. The established model exhibited satisfactory performance in predicting MVI. The C-indices were 0.719, 0.704, and 0.718 in the training, internal validation, and external validation cohorts, respectively. The calibration curves showed an excellent consistency between the predictions and actual observations. Finally, DCA demonstrated that the newly developed nomogram had favorable clinical utility. Conclusions We established and verified a novel preoperative MVI prediction model in HCC patients. This model can be a beneficial tool for clinicians in selecting an optimal treatment plan for HCC patients.

[1]  Yan Zhao,et al.  Computed Tomography Radiomics-Based Prediction of Microvascular Invasion in Hepatocellular Carcinoma , 2022, Frontiers in Medicine.

[2]  Z. Ye,et al.  Prediction of microvascular invasion in HCC by a scoring model combining Gd-EOB-DTPA MRI and biochemical indicators , 2022, European Radiology.

[3]  Xi Yu,et al.  Preoperative nomogram for microvascular invasion prediction based on clinical database in hepatocellular carcinoma , 2021, Scientific Reports.

[4]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[5]  J. Zhong,et al.  The clinical significance of microvascular invasion in the surgical planning and postoperative sequential treatment in hepatocellular carcinoma , 2021, Scientific Reports.

[6]  Chihao Zhang,et al.  Preoperative prediction of microvascular invasion in non-metastatic hepatocellular carcinoma based on nomogram analysis , 2020, Translational oncology.

[7]  Erratum: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. , 2020, CA: a cancer journal for clinicians.

[8]  Lin Wang,et al.  Development and validation of a prediction model for microvascular invasion in hepatocellular carcinoma , 2020, World journal of gastroenterology.

[9]  C. Neuzillet,et al.  Immune Therapy for Liver Cancers , 2019, Cancers.

[10]  Jianhong Lin,et al.  Integrated Nomograms for Preoperative Prediction of Microvascular Invasion and Lymph Node Metastasis Risk in Hepatocellular Carcinoma Patients , 2019, Annals of Surgical Oncology.

[11]  Zhiming Wang,et al.  Nomogram For Preoperative Prediction Of Microvascular Invasion Risk In Hepatocellular Carcinoma , 2019, Cancer management and research.

[12]  C. Murray,et al.  Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 , 2019, The Lancet.

[13]  Ming Ni,et al.  Radiomics models for diagnosing microvascular invasion in hepatocellular carcinoma: which model is the best model? , 2019, Cancer Imaging.

[14]  W. Lau,et al.  The impact of resection margin and microvascular invasion on long-term prognosis after curative resection of hepatocellular carcinoma: a multi-institutional study. , 2019, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[15]  Jing Zhang,et al.  Radiomic analysis of contrast-enhanced CT predicts microvascular invasion and outcome in hepatocellular carcinoma. , 2019, Journal of hepatology.

[16]  D. Xie,et al.  Postoperative adjuvant sorafenib improves survival outcomes in hepatocellular carcinoma patients with microvascular invasion after R0 liver resection: a propensity score matching analysis. , 2019, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[17]  B. Li,et al.  Treatment selection of recurrent hepatocellular carcinoma with microvascular invasion at the initial hepatectomy. , 2019, American journal of translational research.

[18]  W. Rong,et al.  Nomogram to Assist in Surgical Plan for Hepatocellular Carcinoma: a Prediction Model for Microvascular Invasion , 2019, Journal of Gastrointestinal Surgery.

[19]  K. Tanabe,et al.  Prognostic and Therapeutic Implications of Microvascular Invasion in Hepatocellular Carcinoma , 2019, Annals of Surgical Oncology.

[20]  D. Gu,et al.  A Radiomics Nomogram for Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma , 2018, Liver Cancer.

[21]  Yaming Li,et al.  Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition) , 2018, Liver Cancer.

[22]  S. Hyun,et al.  Preoperative prediction of microvascular invasion of hepatocellular carcinoma using 18F-FDG PET/CT: a multicenter retrospective cohort study , 2018, European Journal of Nuclear Medicine and Molecular Imaging.

[23]  T. Ishiko,et al.  Microvascular Invasion in Small-sized Hepatocellular Carcinoma: Significance for Outcomes Following Hepatectomy and Radiofrequency Ablation. , 2018, Anticancer research.

[24]  A. Jemal,et al.  Disparities in liver cancer occurrence in the United States by race/ethnicity and state , 2017, CA: a cancer journal for clinicians.

[25]  L. Mao,et al.  Anatomical versus non‐anatomical resection for solitary hepatocellular carcinoma without macroscopic vascular invasion: A propensity score matching analysis , 2017, Journal of gastroenterology and hepatology.

[26]  W. Cong,et al.  Practice guidelines for the pathological diagnosis of primary liver cancer: 2015 update , 2016, World journal of gastroenterology.

[27]  Kui Wang,et al.  Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatitis B Virus-Related Hepatocellular Carcinoma Within the Milan Criteria. , 2016, JAMA surgery.

[28]  W. Lau,et al.  Postoperative Adjuvant Transcatheter Arterial Chemoembolization After R0 Hepatectomy Improves Outcomes of Patients Who have Hepatocellular Carcinoma with Microvascular Invasion , 2016, Annals of Surgical Oncology.

[29]  A. Jemal,et al.  Cancer statistics in China, 2015 , 2016, CA: a cancer journal for clinicians.

[30]  M. Schwartz,et al.  Recurrence of hepatocellular cancer after resection: patterns, treatments, and prognosis. , 2015, Annals of surgery.

[31]  M. Sata,et al.  The Significance of Classifying Microvascular Invasion in Patients with Hepatocellular Carcinoma , 2014, Annals of Surgical Oncology.

[32]  J. Bruix,et al.  Hepatocellular carcinoma , 2012, The Lancet.

[33]  P. Chow,et al.  Microvascular Invasion Is a Better Predictor of Tumor Recurrence and Overall Survival Following Surgical Resection for Hepatocellular Carcinoma Compared to the Milan Criteria , 2011, Annals of surgery.

[34]  A. Neugut,et al.  Obesity and Microvascular Invasion in Hepatocellular Carcinoma , 2010, Cancer investigation.

[35]  J. Llovet,et al.  A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma. , 2009, Gastroenterology.

[36]  M. Sherman Recurrence of hepatocellular carcinoma. , 2008, The New England journal of medicine.

[37]  G. Raj,et al.  How to build and interpret a nomogram for cancer prognosis. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[38]  Y. N. Park,et al.  Prediction of microvascular invasion before curative resection of hepatocellular carcinoma , 2008, Journal of surgical oncology.

[39]  Timothy M Pawlik,et al.  Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[40]  M. Makuuchi,et al.  Risk factors of post-operative recurrence and adequate surgical approach to improve long-term outcomes of hepatocellular carcinoma. , 2013, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[41]  L. Mariani,et al.  Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. , 2009, The Lancet. Oncology.